UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis

Leukemia, 2007-05, Vol.21 (5), p.912-916

2007

Volltextzugriff (PDF)

Myelodysplastic syndrome associated with trisomy 2

Clinical and laboratory haematology, 2005-08, Vol.27 (4), p.270-273

2005

Volltextzugriff (PDF)

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2

Genes chromosomes & cancer, 2003-05, Vol.37 (1), p.72-78

2003

Volltextzugriff (PDF)

2 or trisomy 2

Atlas of genetics and cytogenetics in oncology and haematology, 2011-02 (4)

Dixon-McIver, A

2011

Volltextzugriff (PDF)

Myelodysplastic syndrome associated with trisomy 2

Clinical & Laboratory Haematology, 2005, Vol.27 (4), p.270-273

2005

Volltextzugriff (PDF)

Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non‐small‐cell lung cancer in New Zealand

Internal medicine journal, 2020-06, Vol.50 (6), p.716-725

2020

Volltextzugriff (PDF)

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia

PloS one, 2008-05, Vol.3 (5), p.e2141-e2141

2008

Volltextzugriff (PDF)

ATR-16 syndrome: mechanisms linking monosomy to phenotype

Journal of medical genetics, 2020-06, Vol.57 (6), p.414-421

2020

Volltextzugriff (PDF)

NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRAS Q61R or KRAS Q61R Mutation in Colorectal Carcinoma

Applied immunohistochemistry & molecular morphology, 2017-08, Vol.25 (7), p.475-480

2017

Volltextzugriff (PDF)

53. Uveal melanoma - The New Zealand perspective

Cancer genetics, 2023-11, Vol.278-279, p.16-17

2023

Volltextzugriff (PDF)

Incorporation of COVID-19 variant testing within a community laboratory using the TaqMan SARS-CoV-2 Mutation Panel

New Zealand journal of medical laboratory science, 2022-11, Vol.76 (3)

2022

Volltextzugriff (PDF)

59. What the TERT? - A telomerase reverse transcriptase case study

Cancer genetics, 2024-08, Vol.286-287, p.S19-S19

2024

Volltextzugriff (PDF)

Determining the optimal input DNA concentration range for AmpFLSTR® identifier™ assay

New Zealand journal of medical laboratory science, 2023-01, Vol.77 (3), p.145-146

2023

Volltextzugriff (PDF)

10. Uveal melanoma: The New Zealand perspective

Cancer genetics, 2020-06, Vol.244, p.4-4

2020

Volltextzugriff (PDF)

Validation of a molecular assay to detect SARS-CoV-2 in saliva

New Zealand medical journal, 2021-12, Vol.134 (1547), p.34-47

Pitman, Janet L

2021

Volltextzugriff (PDF)

39 - Evaluation of Integrating HD-SNP Microarray Into the Workflow for CLL and MM: Challenges and Culture Changes

Cancer genetics, 2017-08, Vol.214-215, p.44-44

2017

Volltextzugriff (PDF)

Evaluation of Integrating HD-SNP Microarray Into the Workflow for CLL and MM: Challenges and Culture Changes

Cancer genetics, 2017-08, Vol.214, p.44-44

2017

Volltextzugriff (PDF)

NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma

Applied immunohistochemistry & molecular morphology, 2017-08, Vol.25 (7), p.475

2017

Volltextzugriff (PDF)

Detection of complex genomic signatures associated with risk in plasma cell disorders

Cancer genetics, 2017-12, Vol.218-219, p.1-9

2017

Volltextzugriff (PDF)

The clinical scientist in diagnostic pathology

New Zealand journal of medical laboratory science, 2011-04, Vol.65 (1), p.12

Dixon-McIver, Amanda

2011

Volltextzugriff (PDF)

MicroRNA detection in bone marrow cells by LNA-FISH

Methods in molecular biology (Clifton, N.J.), 2010, Vol.667, p.33

2010

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis

Myelodysplastic syndrome associated with trisomy 2

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2

2 or trisomy 2

Myelodysplastic syndrome associated with trisomy 2

Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non‐small‐cell lung cancer in New Zealand

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia

ATR-16 syndrome: mechanisms linking monosomy to phenotype

NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRAS Q61R or KRAS Q61R Mutation in Colorectal Carcinoma

53. Uveal melanoma - The New Zealand perspective

Incorporation of COVID-19 variant testing within a community laboratory using the TaqMan SARS-CoV-2 Mutation Panel

59. What the TERT? - A telomerase reverse transcriptase case study

Determining the optimal input DNA concentration range for AmpFLSTR® identifier™ assay

10. Uveal melanoma: The New Zealand perspective

Validation of a molecular assay to detect SARS-CoV-2 in saliva

Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group

39 - Evaluation of Integrating HD-SNP Microarray Into the Workflow for CLL and MM: Challenges and Culture Changes

Evaluation of Integrating HD-SNP Microarray Into the Workflow for CLL and MM: Challenges and Culture Changes

NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma

Detection of complex genomic signatures associated with risk in plasma cell disorders

The clinical scientist in diagnostic pathology

MicroRNA detection in bone marrow cells by LNA-FISH

16 - Genomic Copy Number Aberrations and Copy Neutral Loss of Heterozygosity Evaluation in Myeloid Neoplasms: Evidence-Based Recommendations for Clinical Genetic Testing From the Myeloid Malignancies Working Group of the Cancer Genomics Consortium

Genomic Copy Number Aberrations and Copy Neutral Loss of Heterozygosity Evaluation in Myeloid Neoplasms: Evidence-Based Recommendations for Clinical Genetic Testing From the Myeloid Malignancies Working Group of the Cancer Genomics Consortium

Suchergebnisse filtern